China STEMI Care Project Phase 2 | NCT03011879 | Trialant

China STEMI Care Project Phase 2 | NCT03011879 | Trialant

Sponsor/Collaborators Module

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
1.STEMI patients with symptom onset within 30 days		First round enrollment of STEMI patients with symptom onset within 30 days	Other: clinical pathway
2.STEMI patients with symptom onset within 30 days		Second round enrollment of STEMI patients with symptom onset within 30 days	Other: clinical pathway
3.STEMI patients with symptom onset within 30 days		Third round enrollment of STEMI patients with symptom onset within 30 days	Other: clinical pathway

Interventions

Name	Type	Description	Arm Group Labels	Other Names
clinical pathway	Other		1.STEMI patients with symptom onset within 30 days 2.STEMI patients with symptom onset within 30 days 3.STEMI patients with symptom onset within 30 days

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Referfusion ratio in patients with symptom onset within 12 hours	Referfusion including primary PCI and thrombolysis is the key strategy in STEMI care	12 hours
Door-to-ballnoon time in patients with symptom onset within 12 hours	Door-to-ballnoon time is the key index to evaluate treatment of primary PCI	12 hours
Door-to-needle time in patients with symptom onset within 12 hours	Door-to-needle time is the key index to evaluate treatment of thrombolysis	12 hours
Hospital admission via ambulance ratio		2 years
Symptom onset to arrive in hospital		2 years
Bypass ED ratio in patients with symptom onset within 12 hours		12 hours
Usage of both DAPT, statin, β blocker and ACEI/ARB in patients without contraindication	DAPT means dual antiplatelet therapy	3 yeras
In-hospital morbidity		2 yeras
1-year on time follow-up ratio		1 year

Contacts/Locations Module

Condition Browse Module

Intervention Browse Module